Skip to the page

Data / Drug companies / Amneal Pharmaceuticals Private Limited

Amneal Pharmaceuticals Private Limited: 34 products in the FDA NDC directory, labeler code 80830

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Amneal Pharmaceuticals Private Limited (labeler code 80830) lists 34 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 34 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 20, 2026.

The request: Watch Amneal Pharmaceuticals Private Limited (FDA labeler code 80830): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
80830
Products in commercial distribution
34
Packages
43
Finished drugs by generic name
10
Prescription products
34
Over the counter products
0
Flagged as original packager
33 of 33 products that carry the flag
Started marketing in the last 12 months
16
Earliest marketing start
June 17, 2023
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)3397.1%
New drug applications (NDA)12.9%

Products by type

TypeProductsShare
Prescription drugs34100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection, solution2161.8%
Solution, concentrate514.7%
Injection, emulsion411.8%
Injection, solution, concentrate38.8%
Injection12.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sodium phosphates80830-2310Injection, solutionGeneric drugs (ANDA)October 20, 2026
Sodium Bicarbonate80830-2613Injection, solutionNew drug applications (NDA)July 13, 2026
Iohexol80830-2473Injection, solutionGeneric drugs (ANDA)June 25, 2026
Iohexol80830-2472Injection, solutionGeneric drugs (ANDA)June 25, 2026
Iohexol80830-2471Injection, solutionGeneric drugs (ANDA)June 25, 2026
Iohexol80830-2466Injection, solutionGeneric drugs (ANDA)June 25, 2026
Phytonadione80830-1683Injection, emulsionGeneric drugs (ANDA)June 1, 2026
Calcium gluconate80830-1674Injection, solutionGeneric drugs (ANDA)April 13, 2026
Calcium gluconate80830-1673Injection, solutionGeneric drugs (ANDA)April 13, 2026
Calcium gluconate80830-1672Injection, solutionGeneric drugs (ANDA)April 13, 2026
Sodium Acetate80830-2435Injection, solution, concentrateGeneric drugs (ANDA)March 3, 2026
Cupric chloride80830-2301Injection, solutionGeneric drugs (ANDA)January 29, 2026
Sodium bicarbonate80830-2305Injection, solutionGeneric drugs (ANDA)January 13, 2026
Epinephrine80830-1659InjectionGeneric drugs (ANDA)December 8, 2025
Iohexol80830-2468Injection, solutionGeneric drugs (ANDA)November 13, 2025
Iohexol80830-2467Injection, solutionGeneric drugs (ANDA)November 13, 2025
Sodium acetate80830-2437Injection, solution, concentrateGeneric drugs (ANDA)August 12, 2025
Sodium acetate80830-2436Injection, solution, concentrateGeneric drugs (ANDA)August 12, 2025
Tranexamic acid in sodium chloride80830-2329Injection, solutionGeneric drugs (ANDA)July 9, 2025
Potassium phosphates80830-1691Solution, concentrateGeneric drugs (ANDA)July 9, 2025
Potassium phosphates80830-1691Solution, concentrateGeneric drugs (ANDA)July 9, 2025
Propofol80830-2365Injection, emulsionGeneric drugs (ANDA)August 16, 2024
Propofol80830-2364Injection, emulsionGeneric drugs (ANDA)August 16, 2024
Propofol80830-1188Injection, emulsionGeneric drugs (ANDA)August 16, 2024
Calcium gluconate80830-1674Injection, solutionGeneric drugs (ANDA)May 13, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.